Gilead Sciences Revenue 2006-2019 | GILD

Gilead Sciences annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Gilead Sciences revenue for the quarter ending June 30, 2019 was $5.685B, a 0.66% increase year-over-year.
Gilead Sciences revenue for the twelve months ending June 30, 2019 was $22.357B, a 3.62% decline year-over-year.
Gilead Sciences annual revenue for 2018 was $22.127B, a 15.24% decline from 2017.
Gilead Sciences annual revenue for 2017 was $26.107B, a 14.09% decline from 2016.
Gilead Sciences annual revenue for 2016 was $30.39B, a 6.89% decline from 2015.

Gilead Sciences Annual Revenue (Millions of US $)
2018	$22,127
2017	$26,107
2016	$30,390
2015	$32,639
2014	$24,890
2013	$11,202
2012	$9,702
2011	$8,385
2010	$7,949
2009	$7,011
2008	$5,336
2007	$4,230
2006	$3,026
2005	$2,028

Gilead Sciences Quarterly Revenue (Millions of US $)
Q2 2019	$5,685
Q1 2019	$5,281
Q4 2018	$5,795
Q3 2018	$5,596
Q2 2018	$5,648
Q1 2018	$5,088
Q4 2017	$5,949
Q3 2017	$6,512
Q2 2017	$7,141
Q1 2017	$6,505
Q4 2016	$7,320
Q3 2016	$7,500
Q2 2016	$7,776
Q1 2016	$7,794
Q4 2015	$8,506
Q3 2015	$8,295
Q2 2015	$8,244
Q1 2015	$7,594
Q4 2014	$7,314
Q3 2014	$6,042
Q2 2014	$6,535
Q1 2014	$4,999
Q4 2013	$3,120
Q3 2013	$2,783
Q2 2013	$2,767
Q1 2013	$2,532
Q4 2012	$2,588
Q3 2012	$2,427
Q2 2012	$2,405
Q1 2012	$2,282
Q4 2011	$2,200
Q3 2011	$2,122
Q2 2011	$2,137
Q1 2011	$1,926
Q4 2010	$1,999
Q3 2010	$1,938
Q2 2010	$1,927
Q1 2010	$2,086
Q4 2009	$2,032
Q3 2009	$1,801
Q2 2009	$1,647
Q1 2009	$1,530
Q4 2008	$1,428
Q3 2008	$1,371
Q2 2008	$1,278
Q1 2008	$1,258
Q4 2007	$1,095
Q3 2007	$1,059
Q2 2007	$1,048
Q1 2007	$1,028
Q4 2006	$899
Q3 2006	$749
Q2 2006	$685
Q1 2006	$693
Q4 2005	$609
Q3 2005	$493
Q2 2005	$495
Q1 2005	$430

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$79.622B	$22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

Stock Name	Country	Market Cap	PE Ratio
Amgen (AMGN)	United States	$119.526B	13.61
Celgene (CELG)	United States	$66.133B	10.23
Vertex Pharmaceuticals (VRTX)	United States	$46.554B	50.31
Biogen (BIIB)	United States	$41.986B	7.46
Illumina (ILMN)	United States	$41.861B	49.18
CSL (CSLLY)	Australia	$34.685B	0.00
Regeneron Pharmaceuticals (REGN)	United States	$32.193B	14.61
Actelion (ALIOF)	Switzerland	$29.891B	0.00
Alexion Pharmaceuticals (ALXN)	United States	$24.450B	12.89
Incyte (INCY)	United States	$17.337B	51.02
Exact Sciences (EXAS)	United States	$15.308B	0.00
SINO PHARMACEUT (SBMFF)	China	$15.039B	0.00
BioMarin Pharmaceutical (BMRN)	United States	$12.873B	0.00
Genmab (GNMSF)	Denmark	$12.608B	64.09
Seattle Genetics (SGEN)	United States	$12.406B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$9.477B	50.81
Guardant Health (GH)	United States	$9.197B	0.00
Sarepta Therapeutics (SRPT)	United States	$9.067B	0.00
Alnylam Pharmaceuticals (ALNY)	United States	$8.715B	0.00
Galapagos (GLPG)	Belgium	$8.688B	0.00
QIAGEN (QGEN)	Netherlands	$7.764B	25.50
Bio-Techne Corp (TECH)	United States	$7.304B	50.48
BeiGene (BGNE)	Cayman Islands	$6.704B	0.00
Bluebird Bio (BLUE)	United States	$6.466B	0.00
Exelixis (EXEL)	United States	$6.040B	15.70
Amarin (AMRN)	Ireland	$5.158B	0.00
Horizon Pharma Public (HZNP)	Ireland	$5.004B	12.72
Ascendis Pharma (ASND)	Denmark	$4.838B	0.00
Repligen (RGEN)	United States	$4.555B	88.40
ARGENX SE-ADR (ARGX)	Netherlands	$4.335B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.193B	0.00
Moderna (MRNA)	United States	$4.183B	0.00
Blueprint Medicines (BPMC)	United States	$4.014B	0.00
Spark Therapeutics (ONCE)	United States	$3.853B	0.00
China Biologic Products (CBPO)	China	$3.821B	23.85
MorphoSys AG (MOR)	Germany	$3.777B	0.00
Mirati Therapeutics (MRTX)	United States	$3.541B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$3.281B	0.00
Alkermes (ALKS)	Ireland	$3.276B	0.00
Immunomedics (IMMU)	United States	$2.759B	0.00
Genomic Health (GHDX)	United States	$2.752B	51.61
Arena Pharmaceuticals (ARNA)	United States	$2.635B	5.66
NeoGenomics (NEO)	United States	$2.549B	136.33
Amicus Therapeutics (FOLD)	United States	$2.544B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$2.520B	0.00
Medicines (MDCO)	United States	$2.501B	0.00
MyoKardia (MYOK)	United States	$2.460B	0.00
Acceleron Pharma (XLRN)	United States	$2.372B	0.00
Halozyme Therapeutics (HALO)	United States	$2.319B	0.00
Emergent Biosolutions (EBS)	United States	$2.223B	33.40
Reata Pharmaceuticals (RETA)	United States	$2.197B	0.00
UniQure (QURE)	Netherlands	$2.120B	0.00
Intercept Pharmaceuticals (ICPT)	United States	$2.113B	0.00
Cambrex (CBM)	United States	$2.012B	25.43
Zai Lab (ZLAB)	China	$1.944B	0.00
Akcea Therapeutics (AKCA)	United States	$1.914B	0.00
Ligand Pharmaceuticals (LGND)	United States	$1.745B	22.06
Myriad Genetics (MYGN)	United States	$1.714B	17.98
Denali Therapeutics (DNLI)	United States	$1.689B	0.00
Nabriva Therapeutics AG (NBRV)	Ireland	$1.585B	0.00
Insmed (INSM)	United States	$1.382B	0.00
AnaptysBio (ANAB)	United States	$1.352B	0.00
RA PHARMCTL INC (RARX)	United States	$1.350B	0.00
REGENXBIO (RGNX)	United States	$1.308B	0.00
Coherus BioSciences (CHRS)	United States	$1.291B	0.00
Sangamo Therapeutics (SGMO)	United States	$1.278B	0.00
Editas Medicine (EDIT)	United States	$1.256B	0.00
Orchard Therapeutics (ORTX)	United Kingdom	$1.212B	0.00
Epizyme (EPZM)	United States	$1.168B	0.00
Momenta Pharmaceuticals (MNTA)	United States	$1.165B	0.00
Fate Therapeutics (FATE)	United States	$1.150B	0.00
Athenex (ATNX)	United States	$1.145B	0.00
Innoviva (INVA)	United States	$1.136B	3.28
Alector (ALEC)	United States	$1.023B	0.00
Dicerna Pharmaceuticals (DRNA)	United States	$0.997B	0.00
Zymeworks (ZYME)	Canada	$0.979B	0.00
Twist Bioscience (TWST)	United States	$0.938B	0.00
Cara Therapeutics (CARA)	United States	$0.900B	0.00
Principia Biopharma (PRNB)	United States	$0.868B	452.88
BAVARIAN NORDIC (BVNRY)	Denmark	$0.853B	0.00
ZIOPHARM Oncology Inc (ZIOP)	United States	$0.821B	0.00
Intellia Therapeutics (NTLA)	United States	$0.820B	0.00
ANI Pharmaceuticals (ANIP)	United States	$0.812B	13.55
Adverum Biotechnologies (ADVM)	United States	$0.804B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.794B	28.67
Arvinas (ARVN)	United States	$0.783B	0.00
Codexis (CDXS)	United States	$0.777B	0.00
Alder BioPharmaceuticals (ALDR)	United States	$0.774B	0.00
Anika Therapeutics (ANIK)	United States	$0.760B	26.90
Cytokineticsorporated (CYTK)	United States	$0.733B	0.00
Retrophin (RTRX)	United States	$0.730B	0.00
Pharming Group (PHGUF)	Netherlands	$0.730B	0.00
WAVE Life Sciences (WVE)	Singapore	$0.697B	0.00
Vericel (VCEL)	United States	$0.688B	0.00
Zealand Pharma (ZLDPF)	Denmark	$0.672B	0.00
Zealand Pharma (ZEAL)	Denmark	$0.670B	7.77
Achillion Pharmaceuticals (ACHN)	United States	$0.659B	0.00
Stemline Therapeutics (STML)	United States	$0.634B	0.00
Heska (HSKA)	United States	$0.561B	72.73
MiMedx (MDXG)	United States	$0.555B	0.00
OXFORD BIOMEDCL (OXBDF)	United Kingdom	$0.535B	0.00
DBV Technologies S.A (DBVT)	France	$0.529B	0.00
Intra-Cellular Therapies (ITCI)	United States	$0.498B	0.00
Cellectis S.A (CLLS)	France	$0.489B	0.00
Revance Therapeutics (RVNC)	United States	$0.481B	0.00
Sinovac Biotech (SVA)	China	$0.460B	0.00
Mesoblast (MESO)	Australia	$0.452B	0.00
Precision BioSciences (DTIL)	United States	$0.445B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.438B	0.00
UROGEN PHARMA (URGN)	United States	$0.429B	0.00
Syros Pharmaceuticals (SYRS)	United States	$0.418B	0.00
CytomX Therapeutics (CTMX)	United States	$0.412B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.402B	0.00
BioDelivery Sciences (BDSI)	United States	$0.385B	0.00
AMAG Pharmaceuticals (AMAG)	United States	$0.385B	0.00
Agenus (AGEN)	United States	$0.380B	0.00
PHARMA MAR SA (PHMMF)	Spain	$0.374B	0.00
Merus (MRUS)	Netherlands	$0.369B	0.00
Puma Biotechnology (PBYI)	United States	$0.367B	0.00
Avid Bioservices (CDMO)	United States	$0.360B	0.00
AC Immune SA (ACIU)	Switzerland	$0.347B	25.70
Arcus Biosciences (RCUS)	United States	$0.326B	0.00
Gritstone Oncology (GRTS)	United States	$0.323B	0.00
Biofrontera AG (BFRA)	Germany	$0.323B	0.00
Bellus Health (BLUSF)	Canada	$0.314B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.310B	0.00
Kadmon Holdings (KDMN)	United States	$0.310B	0.00
Scholar Rock Holding (SRRK)	United States	$0.309B	0.00
Theratechnologies (THERF)	Canada	$0.308B	0.00
Prothena (PRTA)	Ireland	$0.303B	0.00
PDL BioPharma (PDLI)	United States	$0.291B	7.50
Clovis Oncology (CLVS)	United States	$0.284B	0.00
Albireo Pharma (ALBO)	United States	$0.282B	0.00
Kindred Biosciences (KIN)	United States	$0.272B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$0.271B	0.00
Sorrento Therapeutics (SRNE)	United States	$0.271B	0.00
Protagonist Therapeutics (PTGX)	United States	$0.263B	0.00
Geron (GERN)	United States	$0.262B	0.00
Dynavax Technologies (DVAX)	United States	$0.255B	0.00
Senesco Technologies (ELOX)	United States	$0.247B	0.00
Pieris Pharmaceuticals (PIRS)	United States	$0.242B	0.00
Cellular Biomedicine (CBMG)	United States	$0.238B	0.00
ADMA Biologics Inc (ADMA)	United States	$0.231B	0.00
ChromaDex (CDXC)	United States	$0.231B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$0.225B	0.00
Aeglea BioTherapeutics (AGLE)	United States	$0.225B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.217B	0.00
Kamada (KMDA)	Israel	$0.212B	8.09
Five Prime Therapeutics (FPRX)	United States	$0.211B	0.00
PHASEBIO PHARMA (PHAS)	United States	$0.204B	0.00
Seres Therapeutics (MCRB)	United States	$0.199B	0.00
MannKind (MNKD)	United States	$0.197B	0.00
Sutro Biopharma (STRO)	United States	$0.196B	0.00
Athersys (ATHX)	United States	$0.188B	0.00
Compugen (CGEN)	Israel	$0.182B	0.00
Spero Therapeutics (SPRO)	United States	$0.179B	0.00
Cue Biopharma (CUE)	United States	$0.171B	0.00
Affimed (AFMD)	Germany	$0.168B	0.00
POXEL SA FRANCE (PXXLF)		$0.167B	0.00
Dyadic (DYAI)	United States	$0.167B	0.00
Newron Pharmaceuticals SpA (NWPHF)		$0.165B	0.00
Novavax (NVAX)	United States	$0.158B	0.00
Emmaus Life Sciences (EMMA)	United States	$0.157B	0.00
Cerecor (CERC)	United States	$0.154B	0.00
Adaptimmune Therapeutics (ADAP)	United Kingdom	$0.153B	0.00
Arsanis (XFOR)	United States	$0.152B	0.00
Nicox SA (NICXF)	France	$0.150B	0.00
OSMOTICA PHARM (OSMT)	United States	$0.149B	0.00
Enzo Biochem (ENZ)	United States	$0.147B	0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT)	United States	$0.147B	0.00
XOMA (XOMA)	United States	$0.144B	0.00
Synlogic (SYBX)	United States	$0.143B	0.00
Strongbridge Biopharma (SBBP)	United States	$0.140B	5.76
Lexicon Pharmaceuticals (LXRX)	United States	$0.140B	0.00
Adocia (ADOCY)	France	$0.140B	0.00
Paratek Pharmaceuticals (PRTK)	United States	$0.136B	0.00
Mersana Therapeutics (MRSN)	United States	$0.132B	0.00
Prometic Life Sciences (PFSCF)	Canada	$0.130B	0.00
Acorda Therapeutics (ACOR)	United States	$0.126B	0.00
Alcobra (ARCT)	United States	$0.126B	0.00
Windtree Therapeutics (WINT)	United States	$0.126B	0.00
NantKwest (NK)	United States	$0.122B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.120B	0.00
Liquidia Technologies (LQDA)	United States	$0.117B	0.00
Nymox Pharmaceutical (NYMX)	Canada	$0.114B	0.00
Celyad SA (CYAD)	Belgium	$0.113B	0.00
SESEN BIO, INC (SESN)	United States	$0.112B	0.00
Aptinyx (APTX)	United States	$0.110B	0.00
Aduro Biotech (ADRO)	United States	$0.108B	0.00
Abeona Therapeutics (ABEO)	United States	$0.107B	0.00
AVEO Pharmaceuticals (AVEO)	United States	$0.107B	0.00
Fortress Biotech (FBIO)	United States	$0.106B	0.00
TOCAGEN INC (TOCA)	United States	$0.104B	0.00
Checkpoint Therapeutics (CKPT)	United States	$0.103B	0.00
Verastem (VSTM)	United States	$0.096B	0.00
OvaScience (MLND)	United States	$0.091B	0.00
Merrimack Pharmaceuticals (MACK)	United States	$0.088B	0.00
Sunesis Pharmaceuticals (SNSS)	United States	$0.087B	0.00
ASLAN Pharmaceuticals (ASLN)	Singapore	$0.086B	0.00
Catalyst Biosciences (CBIO)	United States	$0.085B	0.00
Trevena (TRVN)	United States	$0.083B	0.00
Arbutus Biopharma (ABUS)	Canada	$0.081B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.080B	0.00
Menlo Therapeutics (MNLO)	United States	$0.078B	0.00
Selecta Biosciences (SELB)	United States	$0.074B	0.00
Vaccinex (VCNX)	United States	$0.073B	0.00
Orgenesis (ORGS)	United States	$0.073B	0.00
Catabasis Pharmaceuticals (CATB)	United States	$0.070B	0.00
ARAVIVE, INC (ARAV)	United States	$0.069B	0.00
VTv Therapeutics (VTVT)	United States	$0.068B	0.00
Aridis Pharmaceuticals (ARDS)	United States	$0.067B	0.00
AquaBounty Technologies (AQB)	United States	$0.066B	0.00
Curis (CRIS)	United States	$0.065B	0.00
Spring Bank Pharmaceuticals (SBPH)	United States	$0.064B	0.00
Antibe Therapeutics (ATBPF)	Canada	$0.062B	0.00
Idera Pharmaceuticals (IDRA)	United States	$0.061B	0.00
VBI Vaccines (VBIV)	United States	$0.060B	0.00
Oncobiologics (OTLK)	United States	$0.058B	0.00
NewLink Genetics (NLNK)	United States	$0.057B	0.00
AIT Therapeutics (XAIR)	United States	$0.056B	0.00
Applied Genetic Technologies (AGTC)	United States	$0.055B	30.00
Prima BioMed (IMMP)	Australia	$0.054B	0.00
Pluristem Therapeutics (PSTI)	Israel	$0.054B	0.00
China Health Industries Holdings (CHHE)	China	$0.054B	20.47
Unum Therapeutics (UMRX)	United States	$0.054B	0.00
Invo BioScience (IVOB)	United States	$0.051B	0.00
Ophthotech (ISEE)	United States	$0.046B	0.00
Clearside Biomedical (CLSD)	United States	$0.044B	0.00
Vascular Biogenics (VBLT)	Israel	$0.042B	0.00
Evogene (EVGN)	Israel	$0.039B	0.00
VIVUS (VVUS)	United States	$0.037B	0.00
Organovo Holdings (ONVO)	United States	$0.036B	0.00
Celsion (CLSN)	United States	$0.036B	0.00
Alimera Sciences (ALIM)	United States	$0.036B	0.00
Apricus Biosciences (SEEL)	United States	$0.036B	0.00
AEterna Zentaris (AEZS)	United States	$0.035B	0.00
Aptevo Therapeutics (APVO)	United States	$0.033B	0.00
Proteostasis Therapeutics (PTI)	United States	$0.032B	0.00
Celldex Therapeutics (CLDX)	United States	$0.032B	0.00
BIOCARDIA INC (BCDA)	United States	$0.032B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.031B	0.00
Entera Bio (ENTX)	Israel	$0.030B	0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT)	United States	$0.027B	0.00
Caladrius Biosciences (CLBS)	United States	$0.026B	0.00
Signal Genetics (MGEN)	United States	$0.026B	0.00
Aerpio Pharmaceuticals (ARPO)	United States	$0.025B	0.00
Aytu Bioscience (AYTU)	United States	$0.022B	0.00
Soligenix (SNGX)	United States	$0.021B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.021B	0.00
Bionano Genomics (BNGO)	United States	$0.018B	0.00
Vical (VICL)	United States	$0.018B	0.00
Fibrocell Science Inc (FCSC)	United States	$0.018B	6.00
TRACON Pharmaceuticals (TCON)	United States	$0.016B	0.00
Cleveland BioLabs (CBLI)	United States	$0.016B	0.00
Pulmatrix (PULM)	United States	$0.016B	0.00
Novogen (KZIA)	Australia	$0.015B	0.00
MYOS RENS Technology (MYOS)	United States	$0.014B	0.00
CollPlant Holdings (CLGN)	Israel	$0.013B	0.00
Novelion Therapeutics (NVLN)	Canada	$0.013B	0.00
IMMURON (IMRN)	Australia	$0.011B	0.00
Prana Biotechnology (ATHE)	Australia	$0.010B	0.00
TrovaGene (TROV)	United States	$0.009B	0.00
Benitec Biopharma (BNTC)	Australia	$0.008B	0.00
Cyclacel Pharmaceuticals (CYCC)	United States	$0.008B	0.00
Genetic Technologies (GENE)	Australia	$0.007B	0.00
Advaxis (ADXS)	United States	$0.007B	0.00
Titan Pharmaceuticals (TTNP)	United States	$0.006B	0.00
Stellar Biotechnologies (EDSA)	Canada	$0.004B	0.00
Neuralstem (CUR)	United States	$0.002B	0.00